SUNNYVALE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- BioCardia (BCDA), Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
BERWYN, PA.--(BUSINESS WIRE)--Annovis Bio, Inc. (NYSE: ANVS), announces the positive safety review by the Data and Safety Monitoring Board (DSMB) for its phase III trial of buntanetap, a drug for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results